Literature DB >> 16927029

The intriguing prion disorders.

K Abid1, C Soto.   

Abstract

Prion diseases are among the most intriguing illnesses. Despite their rare incidence, they have captured enormous attention from the scientific community and general public. One of the most hotly debated issues in these diseases is the nature of the infectious material. In recent years increasing evidence has emerged supporting the protein-only hypothesis of prion transmission. In this model PrPSc (the pathological isoform of the prion protein, PrPC) represents the sole component of the infectious particle. However, uncertainties about possible additional factors involved in the conversion of PrPC into PrPSc remain despite extensive attempts to isolate and characterize these elusive components. In this article, we review recent developments concerning the protein-only hypothesis as well as the possible involvement of cellular factors in PrPC to PrPSc conformational change and their influence on the pathogenesis of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927029      PMCID: PMC2804267          DOI: 10.1007/s00018-006-6140-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  109 in total

1.  RNA aptamers specifically interact with the prion protein PrP.

Authors:  S Weiss; D Proske; M Neumann; M H Groschup; H A Kretzschmar; M Famulok; E L Winnacker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  BSE and prions: uncertainties about the agent.

Authors:  B Chesebro
Journal:  Science       Date:  1998-01-02       Impact factor: 47.728

3.  The cellular prion protein binds copper in vivo.

Authors:  D R Brown; K Qin; J W Herms; A Madlung; J Manson; R Strome; P E Fraser; T Kruck; A von Bohlen; W Schulz-Schaeffer; A Giese; D Westaway; H Kretzschmar
Journal:  Nature       Date:  1997 Dec 18-25       Impact factor: 49.962

4.  Kuru: forty years later, a historical note.

Authors:  P P Liberski; D C Gajdusek
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

Review 5.  Potential involvement of retroviral elements in human dementias.

Authors:  L Manuelidis; G Murdoch; E E Manuelidis
Journal:  Ciba Found Symp       Date:  1988

6.  Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation.

Authors:  K Kaneko; L Zulianello; M Scott; C M Cooper; A C Wallace; T L James; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

7.  Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains.

Authors:  M Vey; S Pilkuhn; H Wille; R Nixon; S J DeArmond; E J Smart; R G Anderson; A Taraboulos; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

8.  NMR structure of the mouse prion protein domain PrP(121-231).

Authors:  R Riek; S Hornemann; G Wider; M Billeter; R Glockshuber; K Wüthrich
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

9.  Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).

Authors:  H Budka; A Aguzzi; P Brown; J M Brucher; O Bugiani; F Gullotta; M Haltia; J J Hauw; J W Ironside; K Jellinger
Journal:  Brain Pathol       Date:  1995-10       Impact factor: 6.508

10.  COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform.

Authors:  K Kaneko; M Vey; M Scott; S Pilkuhn; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

View more
  17 in total

1.  Small-molecule aggregates inhibit amyloid polymerization.

Authors:  Brian Y Feng; Brandon H Toyama; Holger Wille; David W Colby; Sean R Collins; Barnaby C H May; Stanley B Prusiner; Jonathan Weissman; Brian K Shoichet
Journal:  Nat Chem Biol       Date:  2008-01-27       Impact factor: 15.040

2.  Self-propagating beta-sheet polypeptide structures as prebiotic informational molecular entities: the amyloid world.

Authors:  C P J Maury
Journal:  Orig Life Evol Biosph       Date:  2009-03-20       Impact factor: 1.950

Review 3.  A structural overview of the vertebrate prion proteins.

Authors:  Annalisa Pastore; Adriana Zagari
Journal:  Prion       Date:  2007-07-08       Impact factor: 3.931

4.  The intrinsic helical propensities of the helical fragments in prion protein under neutral and low pH conditions: a replica exchange molecular dynamics study.

Authors:  Xiaoliang Lu; Juan Zeng; Ya Gao; John Z H Zhang; Dawei Zhang; Ye Mei
Journal:  J Mol Model       Date:  2013-09-17       Impact factor: 1.810

Review 5.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

6.  Effects of pH and aggregation in the human prion conversion into scrapie form: a study using molecular dynamics with excited normal modes.

Authors:  Angelica Nakagawa Lima; Ronaldo Junio de Oliveira; Antônio Sérgio Kimus Braz; Maurício Garcia de Souza Costa; David Perahia; Luis Paulo Barbour Scott
Journal:  Eur Biophys J       Date:  2018-03-15       Impact factor: 1.733

Review 7.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 8.  Prion hypothesis: the end of the controversy?

Authors:  Claudio Soto
Journal:  Trends Biochem Sci       Date:  2010-12-03       Impact factor: 13.807

9.  Effect of electrostatics on aggregation of prion protein Sup35 peptide.

Authors:  Alexander M Portillo; Alexey V Krasnoslobodtsev; Yuri L Lyubchenko
Journal:  J Phys Condens Matter       Date:  2012-03-30       Impact factor: 2.333

10.  Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines.

Authors:  Alessandra Pani; Claudia Norfo; Claudia Abete; Claudia Mulas; Marirosa Putzolu; Sergio Laconi; Christina Doriana Orrù; M Dolores Cannas; Sarah Vascellari; Paolo La Colla; Sandra Dessì
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.